Abstract: Biologically interesting bis-heterocycles bearing pyrazoline and imidazole moieties have been synthesized. 1 H NMR, 13 C NMR, IR and elemental analyses characterized the newly synthesized compounds. All the synthesized compounds were evaluated for their antimicrobial activity and were compared with the standard drugs. All the compounds demonstrated potent to weak antimicrobial activity.
Introduction
The development of simple, facile and efficient synthetic methods for the synthesis of five membered heterocycles from readily available reagents is one of the major challenges in organic synthesis. Among five membered heterocycles, pyrazoline and imidazole are represents a class of compounds of great importance in biological chemistry. For instance, pyrazoline derivatives posses the biological activities like, antidepressant 1 , anticonvulsant 2 antimicrobial 3 , analgesic 4 and antitumour 5 activity and also serves as human acyl-CoA: cholesterol acyltransferase inhibitors. 6 In fact, celecoxib a pyrazole derivative is now widely used in the market as anti-inflammatory drug. 7 Imidazole derivatives are gaining synthetic interest in recent years due to their broad spectrum of biological activities like antiinflammatory 8 , analgesic 9 , antibacterial 10 , antifungal 11 , antituberculosis 12 , anticonvolusant 13 and potential anticytokine agents 14 . 2-n-Butyl-4-chloro-5-farmyl-imidazole is a key intermediate for the synthesis of Losartan a nonpeptide angiotensin antagonist, which is an orally active antihypertensive drug 15 . Literature studies reveals that bis-heterocycles bearing pyrazoline 16, 17 were synthesized via 1,3-dipolar cycloaddition of aldehyde hydrazone to divinyl ketone / sulfone using chloramine-T (CAT) as dehydrating agent.
1,3-Dipolar cycloaddition reactions are useful tools for constructing biologically potent five membered heterocycles 18 . Apart from the various dipolar reagents known, nitrile imines are used in numerous 1,3-dipolar cycloaddition reactions leading to pyrazoles, pyrazolines, pyrazolidines and other heterocyclic compounds 19 . Huisgen and co-workers 20 first reported the authentic in situ generation of nitrile imines by the thermolysis of 2,5-diphenyl tetrazole in the presence of ethyl phenylpropionate and obtained 2,3,5-triphenyl carbethoxypyrazole. Nitrile imines can be generated by photolysis of sydnones 21 and oxidation of aryl aldehyde hydrazones with lead tetraacetate 22 , chloramine-T 23 etc. In our laboratory Rai et al extensively used chloramine-T for the generation of nitrile oxide and nitrile imine from aldoxime and aldehyde hydrazones respectively. With this background, it is considered worthwhile to prepare bis-heterocycles using 1,3-dipolar cycloaddition reaction of 2-n-butyl-4-chloro-(N-substituted)-imidazole substituted nitrile imine with different olefins and screen them for antimicrobial activity. The present communication deals with the synthesis of bis-heterocycles via 1,3-dipolar cycloaddition reactions and their antimicrobial activity. Experimental 1 H NMR spectra were recorded on a Bruker AM 300 MHz spectrometer using CDCl 3 as solvent and tetramethylsilane as internal standard. 13 C NMR spectra were measured on Jeol 400 (100MHz) instrument. The chemical shifts are expressed in δ and following abbreviations were used: s = singlet, d = doublet, t = triplet and m = multiplet. Infrared (IR) spectra were measured on Shimadzu 8300 spectrometer. Elemental analyses were obtained on a Vaio-EL intrument. Thinlayer chromatography (TLC) was done with pre-coated silica gel G plates using benzene-ethylacetrate as eluent.
Antimicrobial activity
All the synthesized compounds were evaluated for antimicrobial activity by the disc diffusion method 26 and microdilution method 27 
Preparation of 4'-(2-Butyl-4-chloro-5-formyl-imidazol-1-ylmethyl)-2-carbonitrile (2)
A mixture of 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde (1.0 g, 5.37 mmol) and anhyd. K 2 CO 3 (0.90 g, 6.52 mmol) in dimethylformamide (15 mL) were stirred for 15 min at room temperature. 4'-Bromomethyl-biphenyl-2-carbonitrile (1.45 g, 5.33 mmol) was then added and the mixture was stirred at room temperature for 6 h. After completion of the reaction (TLC toluene-ethylacetate; 7:3) the reaction mass was diluted with 25 mL water and the product was extracted with dichloromethane (25 mL). The extract was washed with water (10 mL) and then dried (Na 2 SO 4 ). The solvent was evaporated and the remaining pale yellow oil was crystallized from ethanol to give 2 as a white crystalline solid (1.81 g 89%), mp 108-110 o C.
Synthesis of 4,5-dihydro-3-(substituted-imidazole)-1,5-diphenyl-1H-pyrazoline (5a)
A mixture of 3 (1.0 g, 2.13 mmol), 4a (0.23 g, 2.2 mmol) and chloramine-T trihydrate (0.6 g, 2.13 mmol) in ethanol (20 mL) was warmed on a water bath for 2-3 h. TLC monitored the progress of the reaction. After completion of the reaction the solvent was evaporated in vacuum. The residual mass was extracted into ether (25 mL), washed successively with water (2 x 20 mL), 5% NaOH (1 x 10 mL), brine solution (2 x 15 mL) and dried over anhydrous sodium sulphate. Evaporation of the solvent afforded crude oily substance, which was purified by column chromatography using benzene-ethylacetate (8:1) as eluent to give the product as thick oil (0.75 g, 62%).
4,5-dihydro-3-(substituted-imidazole)-5-methyl-1,5-diphenyl-1H-pyrazoline (5b)
Obtained from 3 (1.0 g, 2.13 mmol), 4b (0.25 g, 2.12 mmol) and chloramine-T trihydrate (0.6 g, 2.13 mmol) as thick oil (0.88 g, 70%).
4,5-dihydro-3-(substituted-imidazole)-1-phenyl-1H-pyrazoline-5-carbonitrile (5c)
Obtained from 3 (1.0 g, 2.13 mmol), 4c (0.12 g, 2.20 mmol) and chloramine-T trihydrate (0.6 g, 2.13 mmol) as thick oil (0.7 g, 63%).
5-(Chloromethyl)-4,5-dihydro-3-(substituted-imidazole)-1-phenyl-1H-pyrazoline (5d)
Obtained from 3 (1.0 g, 2.13 mmol), 4d (0.17 g, 2.23 mmol) and chloramine-T trihydrate (0.6 g, 2.13 mmol) as thick oil (0.73 g, 63%).
5-(bromomethyl)-4,5-dihydro-3-(substituted-imidazole)-1-phenyl-1H-pyrazoline (5e)
Obtained from 3 (1.0 g, 2.13 mmol), 4e (0.26 g, 2.14 mmol) and chloramine-T trihydrate (0.6 g, 2.13 mmol) as thick oil (0.82 g, 66%).
4,5-dihydro-3-(substituted-imidazole)-1-phenyl-1H-pyrazol-yl)methanol (5f)
Obtained from 3 (1.0 g, 2.13 mmol), 4f (0.125 g, 2.15 mmol) and chloramine-T trihydrate (0.6 g, 2.13 mmol) as thick oil (0.68 g, 61%).
4,5-dihydro-3-(substituted-imidazole)-1-phenyl-1H-pyrazol-5-yl acetate (5g)
Obtained from 3 (1.0 g, 2.13 mmol), 4g (0.185 g, 2.15 mmol) and chloramine-T trihydrate (0.6 g, 2.13 mmol) as thick oil (0.91 g, 77 %).
4,5-dihydro-3-(substituted-imidazole)-1-phenyl-1H-pyrazol-5-yl propionate (5h)
Obtained from 3 (1.0 g, 2.13 mmol), 4h (0.215 g, 2.15 mmol) and chloramine-T trihydrate (0.6 g, 2.13 mmol) as thick oil (0.92 g, 76%).
Results and Discussion
The general synthetic pathway discussed hereafter is depicted in the Scheme. Compound 1 was alkylated using 4'-Bromomethyl-biphenyl-2-carbonitrile and potassium carbonate in DMF. Then farmyl function of 2 was converted into the phenylhydrazone 3. When oxidative dehydrogenation of 3 by chloramine-T (CAT) afforded nitrile imine, which was in situ trapped by the different olefins 4 (a-h) under refluxing condition in ethanol. Thus produced compound was identified by NMR spectroscopy and elemental analyses as 4,5-dihydro-3-(substituted imidazole)-5-substituted-1-phenyl-1H-pyrazoline 5 (a-h) in good quality and yield. The starting substrate 2-n-butyl-4-chloro-(N-substituted)-imidazole-5-carbaldehyde 1 was prepared according to literature procedure 24 . Imidazole aldehyde phenylhydrazone was prepared by known procedure 25 .
Antimicrobial activity
Antimicrobial activity of all the compounds was shown in Table 1 and 2. Among the series of synthesized compounds, 5d and 5e shown better inhibition. Remaining compounds shown moderate inhibition. The better inhibition shown by 5d and 5e may be due to the presence of chloro and bromo group in the compound. 13 
Spectral analysis of compounds

Conclusion
In conclusion 4, 5-dihydro -3-(substituted -imidazole) -5 -substituted-1-phenyl-1H-pyrazoline derivatives were synthesized and their antimicrobial activity have been evaluated. Compounds 5d and 5e shows significant inhibition, remaining compounds demonstrated potent to moderate antimicrobial activity. Further research in this area is under progress in our laboratory.
